Table 1. Plasma PQQ and mtDNA/nuclear DNA Ratio Levels.
PQQ (nM) in Plasma and Tissues | ||||
Parameters | PQQ Treatments1,2 | |||
Experiment Designation | Tissue | PQQ+ | PQQ− | PQQ−/+ |
Lipid Assessment | Plasma (Adult) | 5.2±1.3 | 3.5±2.1* | 17.0±4.5** |
Liver (Adult) | 21.3±16.4 | 5.4±2.6** | 26.1±17.2 | |
Heart (Adult) | 3.4±1.9 | 2.4±1.0* | 13.6±10.2* | |
Energy, Glucose, insulin, FFA Assessment | Plasma(Weanling/young) | 10.1±4.7 | 0.71±0.35*** | 16.4±2.9 |
Glucose, insulin, FFA | Plasma (Adult) | 11.3±6.7 | 2.6±1.35** | 18.5±4.9 |
Ischemia Reperfusion | Plasma (Adult) | 10.7±2.1 | 0.7±1.5** | ND |
mtDNA/NuclearDNA Ratio3 | ||||
Lipid Assessment | Liver (Adult) | 1.0±0.18 | 0.78±0.12** | 1.3±0.06 |
Energy, Glucose, insulin, FFA Assessment | Liver(Weanling/young) | 1.0±0.18 | 0.84±0.07 | 1.06±0.08 |
Glucose, insulin, FFA | Liver (Adult) | 1.06±0.19 | 0.77±0.15* | 1.28±0.19 |
Heart (Adult) | 1.0±0.21 | 0.85±0.17 | 1.1±0.2 | |
Ischemia Reperfusion | Liver (Adult) | 1.0±0.08 | 0.72±0.1** | 1.1±0.1 |
Rats were fed an amino acid-based semi-purified diet either deficient in PQQ (PQQ−) or with PQQ added at 2 mg/kg diet (PQQ+). Rats initially fed PQQ− diets were also repleted with PQQ by i.p. injection (4.5 mg PQQ/Kg BW/24 hours X 3).
The superscripts *, **, *** represent significance relative to the PQQ+ group at p<0.2; <0.05; or p<0.01, respectively.
The relative amounts of liver mitochondrial DNA (mtDNA) and nuclear DNA were measured by real-time PCR. The targeted genes were the nuclear cystic fibrosis and the mitochondrial nicotinamide adenine dinucleotide dehydrogenase-5 gene. When corresponding values for liver in each experiment are averaged, the liver values were significant at p<0.01 (PQQ+ vs PQQ− and PQQ+ vs PQQ −/+ based on ANOVA analysis using a Bonferoni correction); for heart, p<0.3.